Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Pharma Fund | Baroda BNP Paribas Business Cycle Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Nippon India | Baroda BNP |
| NAV | ₹666.3420 | ₹18.0677 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 13.9 years | 5.2 years |
| Expense ratio | 1.0% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 75.20 | 48.00 |
Returns
| Nippon India Pharma Fund | Baroda BNP Paribas Business Cycle Fund | |
|---|---|---|
| 1 month | +11.40% | +9.18% |
| 3 months | +3.74% | +3.13% |
| 6 months | +8.55% | +8.62% |
| YTD | +16.94% | +5.48% |
| 1 year | +15.26% | +5.68% |
| 3 years (CAGR) | +17.96% | +13.61% |
| 5 years (CAGR) | +15.40% | +12.45% |
| 10 years (CAGR) | +16.61% | — |
| Since launch | +17.63% | +12.09% |
Risk
| Nippon India Pharma Fund | Baroda BNP Paribas Business Cycle Fund | |
|---|---|---|
| Volatility | 14.1% | 16.4% |
| Downside volatility | 9.0% | 11.0% |
| Sharpe | 0.81 | 0.43 |
| Sortino | 1.28 | 0.65 |
| Calmar | 1.22 | 0.67 |
| Return / risk | 1.27 | 0.83 |
| Deepest fall | −24.02% | −20.27% |
| Days to recover | 445 | 621 |
| Below its high | +0.00% | +0.00% |
Against benchmark
| Nippon India Pharma Fund | Baroda BNP Paribas Business Cycle Fund | |
|---|---|---|
| Alpha | −1.86% | +1.67% |
| Beta | 0.89 | 1.00 |
| R² | 89.5% | 96.0% |
| Up capture | 85.2% | 107.1% |
| Down capture | 88.7% | 101.3% |
| Tracking error | 4.8% | 3.3% |
| Information ratio | −0.69 | 0.50 |
| Treynor | 0.12 | 0.06 |
Consistency
| Nippon India Pharma Fund | Baroda BNP Paribas Business Cycle Fund | |
|---|---|---|
| Best 1-year | +90.70% | +51.92% |
| Middle 1-year | +13.13% | +7.52% |
| Worst 1-year | −15.12% | −9.50% |
| 1-year periods with a loss | 23.2% | 14.8% |
| Middle 3-year | +19.82% | +17.11% |
| Positive months | 63.9% | 63.9% |
| Best day | +3.40% | +3.55% |
| Worst day | −3.21% | −6.39% |
| Worst 5% day | −1.38% | −1.42% |
| Positive days | 53.7% | 56.4% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Pharma Fund | Baroda BNP Paribas Business Cycle Fund | |
|---|---|---|
| 5-year XIRR | +18.24% | +12.89% |
| 5-year value | ₹9,54,076 | ₹8,34,504 |
| 3-year XIRR | +14.26% | +8.40% |
| 1-year XIRR | +22.08% | +13.44% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.